Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway

Fig. 1

Characterization of MSCs, survival of MSCs, and erectile response after treatments. a The isolated cells express the MSC markers, CD29 and CD90, but do not express the hematopoietic or endothelial markers CD34 and CD45. b Comparisons of survival status of MSCs in different states (3 days; 1 week; 2 weeks) in frozen section. Fluorescence represents changes in the survival of the MSCs. n = 6 per group. c Treatment of probucol and MSCs improves erectile dysfunction elicited by electrical stimulation of the cavernous nerve. The colored bar denotes the 60s CN electrical stimulation. Ratios of max ICP to MAP of all the three groups were presented through bar graphs for max ICP/MAP. Data are expressed as mean ± standard deviation, n = 6. **P < 0.01 indicates significant difference compared with the sham group. ##P < 0.01 indicates significant difference compared with the DM group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512